Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome

Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome

Show other versions (1)

Background: Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine illnesses affecting reproductive - age women. L-carnitine has important roles in oxidative stress, energy production and glucose metabolism. It affects insulin resistance as decreased plasma carnitine level has been...

Full description

Bibliographic Details
Main Authors:	Maad M. Shallal, Najmah Mahmood, Zina A. Hussein
Format:	Article
Language:	English
Published:	College of Medicine University of Baghdad 2023-04-01
Series:	مجلة كلية الطب
Subjects:	L-Carnitine, Insulin resistance, PCOS : L-Carnitine, Insulin resistance, Obesity, Women, PCOS.
Online Access:	https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2040

Similar Items

Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome
by: Maad M. Shallal, et al.
Published: (2023-04-01)

Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol
by: Alessandro D. Genazzani, et al.
Published: (2025-12-01)

Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients
by: Tabatha Petrillo, et al.
Published: (2022-08-01)

Effect of pioglitazone treatment on serum chemerin and vaspin levels in polycystic ovary syndrome.
by: Rana Hussein Kutaif, et al.
Published: (2022-04-01)

Morphological and Redox/Glycative Alterations in the PCOS Oviducts: Modulating Effects of Carnitines in PCOS Mice
by: Mariacarla De Rubeis, et al.
Published: (2024-11-01)

Evaluation of serum adiponectin as a marker of insulin resistance in women with polycystic ovarian syndrome: a comparative cross-sectional study
by: Olugbenga Ojatokunbo Runsewe, et al.
Published: (2024-02-01)

The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome
by: Nadia B. Pateguana, et al.
Published: (2019-07-01)

The latest reports and treatment methods on polycystic ovary syndrome
by: Natalia Anna Stańczak, et al.
Published: (2024-12-01)

Assessment of early vascular changes in adult females with polycystic ovary syndrome: correlation with insulin resistance
by: Shrook Mousa, et al.
Published: (2023-12-01)

Investigation of serum asprosin level in patients diagnosed of polycystic ovary syndrome in adolescent age
by: Merve Gungor, et al.
Published: (2022-12-01)

The Potential for Ketogenic Diets to Control Glucotoxicity, Hyperinsulinemia, and Insulin Resistance to Improve Fertility in Women with Polycystic Ovary Syndrome
by: Leticia Ramírez-Martínez, et al.
Published: (2024-03-01)

The Comparative Effects of Myo-Inositol and Metformin Therapy on the Clinical and Biochemical Parameters of Women of Normal Weight Suffering from Polycystic Ovary Syndrome
by: Aleksandra Gudović, et al.
Published: (2024-02-01)

Association of Circulating Spexin Levels with Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Women and Normal Controls
by: Maliha Shameem, et al.
Published: (2023-12-01)

Association of Circulating Spexin Levels with Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Women and Normal Controls
by: Maliha Shameem, et al.
Published: (2023-12-01)

Interleukin–33, Oxidative Stress in Prediabetic Polycystic Ovary Syndrome Patients with Insulin Resistance
by: Wafa F. Al-Taie, et al.
Published: (2014-04-01)

Polycystic Ovary Syndrome (PCOS): Insights into Etiology, Genetic, Diagnosis, Treatment, and Future Directions. (A Comprehensive Review)
by: Lujain Ghannawi, et al.
Published: (2024-12-01)

A nomogram to predict the risk of insulin resistance in Chinese women with polycystic ovary syndrome
by: Benjie Guo, et al.
Published: (2024-11-01)

Decreased Serum Levels of the Insulin Resistance-Related microRNA miR-320a in Patients with Polycystic Ovary Syndrome
by: Sarina Vogt, et al.
Published: (2024-04-01)

The current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
by: Justyna Lipińska, et al.
Published: (2024-02-01)

Acetate attenuates hypothalamic pyroptosis in experimentally induced polycystic ovarian syndrome
by: Kehinde S. Olaniyi, et al.
Published: (2024-09-01)

Investigation of the Effect of Nano-melatonin on Oxidative Stress in Sera of Patients with Polycystic Syndrome
by: Shahad Abbas Hameed, et al.
Published: (2024-09-01)

Editorial: Mechanisms involved in the development of obesity with PCOS
by: Anju E. Joham, et al.
Published: (2024-07-01)

Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome
by: Emre Uysal, et al.
Published: (2024-08-01)

Mangiferin ameliorates polycystic ovary syndrome in rats by modulating insulin resistance, gut microbiota, and ovarian cell apoptosis
by: Zhang Yong, et al.
Published: (2024-09-01)

Glucose Insulin Ratio in Hyper Insulinemic Women with Polycystic Ovarian Syndrome
by: Roohi Jabbar, et al.
Published: (2022-06-01)

Liver Histology of Male Rat (Rattus norvegicus) Feed L-Carnitine Supplement
by: Anak Agung Istri Mas Padmiswari, et al.
Published: (2024-07-01)

Chemerin and Polycystic Ovary Syndrome: A Comprehensive Review of Its Role as a Biomarker and Therapeutic Target
by: Stefano Palomba, et al.
Published: (2024-12-01)

Rational Design, Synthesis, and In Vitro Activity of Heterocyclic Gamma-Butyrobetaines as Potential Carnitine Acetyltransferase Inhibitors
by: Savina Stoyanova, et al.
Published: (2025-02-01)

Gut microbiota: an emerging target connecting polycystic ovarian syndrome and insulin resistance
by: Yufeng Mei, et al.
Published: (2025-03-01)

Oral L-Carnitine used to treat narcoleptic type 1 patient during pregnancy - A case report
by: Felipe Barros, et al.
Published: (2018-12-01)

Impaired glucose tolerance and insulin resistance in a prenatally‐androgenized rat model of polycystic ovary syndrome in later life
by: Mahbanoo Farhadi‐Azar, et al.
Published: (2025-03-01)

Polymorphism of the Insulin Resistin (RETN) gene in susceptibility to Polycystic Ovary Syndrome (PCOS) in an Iranian population
by: Masoomeh Bahmanpoori Ghalehzan, et al.
Published: (2025-02-01)

Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators
by: Xiao-li Li, et al.
Published: (2024-12-01)

Body Image and Other Mood Vulnerabilities in Adolescents with Polycystic Ovary Syndrome and Metabolic Alterations
by: Federica Barbagallo, et al.
Published: (2024-04-01)

The Combined Effect of Basic Gymnastics Exercises and L-Carnitine Supplementation on Physical Factors Related to Health and Lipid Profile in Obese Female Children (Original article)
by: Soheila Fakhrian Roghani, et al.
Published: (2023-12-01)

The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review
by: Salvatore Giovanni Vitale, et al.
Published: (2022-07-01)

The effect of adding L. Carnitine with herbal methionine and sunflower seed oil on production characteristics of broilers
by: Selma Kareem, et al.
Published: (2022-12-01)

Comparison of body mass index, anti-müllerian hormone and insulin resistance parameters among different phenotypes of polycystic ovary syndrome
by: Türkan Gürsu, et al.
Published: (2022-12-01)

Effects of L-carnitine supplementation on lipid profile in adult patients under hemodialysis: a systematic review and meta-analysis of RCTs
by: Mehdi Karimi, et al.
Published: (2024-12-01)

Comprehensive Management of Polycystic Ovary Syndrome: The Role of Metformin in Addressing Metabolic and Endocrine Dysregulation
by: Martyna Kaźmierczak, et al.
Published: (2025-01-01)